Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

11

Revenue 2014

AbbVie

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AbbVie's 2013 sales performance.

Samsung deal with Takeda looks beyond biosimilars

Samsung deal with Takeda looks beyond biosimilars

AbbVie's Humira (adalimumab) and Roche's Herceptin (trastuzumab).

SMC gives green light for Amgen’s Kyprolis

SMC gives green light for Amgen’s Kyprolis Continuing with the cancer field, AbbVie’s Venclyxto (venetoclax) also won SMC approval for the treatment of chronic lymphocytic leukaemia (CLL) in adult patients.

SMC gives green light for Amgen’s Kyprolis

SMC gives green light for Amgen’s Kyprolis Continuing with the cancer field, AbbVie’s Venclyxto (venetoclax) also won SMC approval for the treatment of chronic lymphocytic leukaemia (CLL) in adult patients.

Setback for J&J as FDA panel turns down arthritis drug sirukumab

Setback for J&J as FDA panel turns down arthritis drug sirukumab Sarilumab also outperformed AbbVie's market-leading, $13bn-a-year TNF blocker Humira (adalimumab) in head-to-head trials, while sirukumab achieved mixed results, besting its rival on one measure but

Clock starts ticking on FDA review of AZ's acalabrutinib

Clock starts ticking on FDA review of AZ's acalabrutinib The US regulator has also awarded acalabrutinib a priority review, setting up a possible approval for the drug - which is a rival to Johnson &Johnson/AbbVie's big-selling Imbruvica (ibrutinib) -

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
McCann Health

The most globally awarded health agency network and currently Health Network agency of The Year. Comprising of two specialist agencies:...

Latest intelligence

The_Pharma_Wars_Series.png
The Pharma Wars Series
The future galaxy is complex. Where markets are more competitive and customers more segmented, you’ve got to be smarter. But not only smarter, the Jedi today needs to be everywhere...
What pharma marketers can learn from growth hacking?
Growth hackers instinctively blend technical skills with creative thinking...
Medicines for Europe
The sound of silence puts the squeeze on generics and biosimilars
Medicines for Europe vows to get governments talking to realise potential...

Infographics